Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: ALTEX. 2022 Sep 15;40(2):248–270. doi: 10.14573/altex.2203041

Fig. 8: PPAR reference agonist effects in Diversity Plus panel.

Fig. 8:

Profiles for PPARg agonists rosiglitazone (3.7 μM, blue circle), pioglitazone (10 μM, green triangle) and PPARa agonists gemfibrozil (200 μM, red diamond) and oleoylethanolamide (1.1 μM, large orange diamond) are shown for the 12 assay systems of the BioMAP Diversity Plus panel. Concentrations were selected from the database to exceed reported in vitro EC50 values for the corresponding receptor targets by 5- to 40-fold.